Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ocado facing opposition to £15m bonus for Tim Steiner

(Sharecast News) - Ocado fell on Monday following a report over the weekend suggesting the company is under pressure over executive pay after an influential proxy adviser urged shareholders to vote against a new bonus scheme that could see boss Tim Steiner paid as much as £14.8m. According to The Times, Institutional Shareholder Services has recommended that investors vote against the online grocer's new remuneration policy and performance share plan at its annual meeting on April 29, citing "material concerns" over the sum of money executives could receive.

According to The Times, ISS said the potential amount on offer was "materially above market norms" and "not in line with UK market standards and investor expectations".

In a report circulated to clients, it identified the company's remuneration as a "high concern", which it said was "exacerbated by the shareholder experience, with no dividend and a general decline in the company's share price over the past few years".

The FTSE 100 company wants to set up an incentive scheme that could pay an award to Steiner worth as much as 1,800% of his £824,570 base salary if the share price reaches £29.69 in three years' time and other performance targets are met.

Under the new proposals, Steiner would be able to receive an award worth 600% of his base salary, or almost £5m, even if targets for total shareholder returns and other performance measures are met but the share price goal is missed.

Ocado proposed the bumper award in its new remuneration policy, in which it said it was mindful of Steiner's "unique position" as a founder of the company and his "longer-term focus and strategic vision".

Shareholders will be required to approve the revised policy.

At 1210 GMT, the shares were down 3.9% at 450.20p.

Share this article

Related Sharecast Articles

Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.
Supermarket Income REIT buys portfolio of Carrefour supermarkets for €75.3m
(Sharecast News) - Supermarket Income REIT said on Monday that it has bought a portfolio of Carrefour supermarkets in France through a sale and leaseback transaction for €75.3m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.